Clinical trial
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus…
NCT00042523 · National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH · Completed
Key facts
| NCT number | NCT00042523 |
|---|---|
| Title | Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus |
| Official title | Role of the Antibody Against NR2 Glutamate Receptor in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus |
| Lead sponsor | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIH |
| Status | Completed |
| Study type | Observational |
| Conditions | Systemic Lupus Erythematosus |
| Enrollment | 61 |
| Start date | Jul 1, 2002 |
| Completion | Jan 1, 2005 |
| First posted | Aug 1, 2002 |
| Last update posted | Mar 4, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: